IBDEI0YK ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15397,0)
 ;;=C7A.024^^85^847^23
 ;;^UTILITY(U,$J,358.3,15397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15397,1,3,0)
 ;;=3^Carcinoid,Malignant,Descending
 ;;^UTILITY(U,$J,358.3,15397,1,4,0)
 ;;=4^C7A.024
 ;;^UTILITY(U,$J,358.3,15397,2)
 ;;=^5001367
 ;;^UTILITY(U,$J,358.3,15398,0)
 ;;=C7A.025^^85^847^28
 ;;^UTILITY(U,$J,358.3,15398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15398,1,3,0)
 ;;=3^Carcinoid,Malignant,Sigmoid
 ;;^UTILITY(U,$J,358.3,15398,1,4,0)
 ;;=4^C7A.025
 ;;^UTILITY(U,$J,358.3,15398,2)
 ;;=^5001368
 ;;^UTILITY(U,$J,358.3,15399,0)
 ;;=C7A.026^^85^847^27
 ;;^UTILITY(U,$J,358.3,15399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15399,1,3,0)
 ;;=3^Carcinoid,Malignant,Rectum
 ;;^UTILITY(U,$J,358.3,15399,1,4,0)
 ;;=4^C7A.026
 ;;^UTILITY(U,$J,358.3,15399,2)
 ;;=^5001369
 ;;^UTILITY(U,$J,358.3,15400,0)
 ;;=C7A.029^^85^847^31
 ;;^UTILITY(U,$J,358.3,15400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15400,1,3,0)
 ;;=3^Carcinoid,Malignant,Unspec Colon
 ;;^UTILITY(U,$J,358.3,15400,1,4,0)
 ;;=4^C7A.029
 ;;^UTILITY(U,$J,358.3,15400,2)
 ;;=^5001370
 ;;^UTILITY(U,$J,358.3,15401,0)
 ;;=C7B.02^^85^847^5
 ;;^UTILITY(U,$J,358.3,15401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15401,1,3,0)
 ;;=3^Carcinoid of Liver
 ;;^UTILITY(U,$J,358.3,15401,1,4,0)
 ;;=4^C7B.02
 ;;^UTILITY(U,$J,358.3,15401,2)
 ;;=^5001383
 ;;^UTILITY(U,$J,358.3,15402,0)
 ;;=E34.0^^85^847^6
 ;;^UTILITY(U,$J,358.3,15402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15402,1,3,0)
 ;;=3^Carcinoid syndrome
 ;;^UTILITY(U,$J,358.3,15402,1,4,0)
 ;;=4^E34.0
 ;;^UTILITY(U,$J,358.3,15402,2)
 ;;=^19261
 ;;^UTILITY(U,$J,358.3,15403,0)
 ;;=C83.79^^85^847^33
 ;;^UTILITY(U,$J,358.3,15403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15403,1,3,0)
 ;;=3^Lymphoma,Burkitt,Extranodal
 ;;^UTILITY(U,$J,358.3,15403,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,15403,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,15404,0)
 ;;=C83.39^^85^847^34
 ;;^UTILITY(U,$J,358.3,15404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15404,1,3,0)
 ;;=3^Lymphoma,Diffuse large B-Cell,Extranodal
 ;;^UTILITY(U,$J,358.3,15404,1,4,0)
 ;;=4^C83.39
 ;;^UTILITY(U,$J,358.3,15404,2)
 ;;=^5001580
 ;;^UTILITY(U,$J,358.3,15405,0)
 ;;=C86.2^^85^847^35
 ;;^UTILITY(U,$J,358.3,15405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15405,1,3,0)
 ;;=3^Lymphoma,Enteropathy T-cell type
 ;;^UTILITY(U,$J,358.3,15405,1,4,0)
 ;;=4^C86.2
 ;;^UTILITY(U,$J,358.3,15405,2)
 ;;=^5001743
 ;;^UTILITY(U,$J,358.3,15406,0)
 ;;=C82.59^^85^847^36
 ;;^UTILITY(U,$J,358.3,15406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15406,1,3,0)
 ;;=3^Lymphoma,Follicular Diffuse,Extranodal
 ;;^UTILITY(U,$J,358.3,15406,1,4,0)
 ;;=4^C82.59
 ;;^UTILITY(U,$J,358.3,15406,2)
 ;;=^5001520
 ;;^UTILITY(U,$J,358.3,15407,0)
 ;;=C88.4^^85^847^37
 ;;^UTILITY(U,$J,358.3,15407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15407,1,3,0)
 ;;=3^Lymphoma,MALT Type
 ;;^UTILITY(U,$J,358.3,15407,1,4,0)
 ;;=4^C88.4
 ;;^UTILITY(U,$J,358.3,15407,2)
 ;;=^5001749
 ;;^UTILITY(U,$J,358.3,15408,0)
 ;;=C83.19^^85^847^38
 ;;^UTILITY(U,$J,358.3,15408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15408,1,3,0)
 ;;=3^Lymphoma,Mantle cell,Extranodal
 ;;^UTILITY(U,$J,358.3,15408,1,4,0)
 ;;=4^C83.19
 ;;^UTILITY(U,$J,358.3,15408,2)
 ;;=^5001570
 ;;^UTILITY(U,$J,358.3,15409,0)
 ;;=C78.6^^85^847^39
 ;;^UTILITY(U,$J,358.3,15409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15409,1,3,0)
 ;;=3^Peritoneal carinomatosis
